Clinical trial NCT06357130: Gynaecological Care for Transgender People in France in 2024.
Official title: Gynaecological Care for Transgender People in France in 2024.
Study type: OBSERVATIONAL
Overall status: RECRUITING
Conditions: Transgender Management Care
Keywords: Gynaecology
Gender-affirming hormonal therapy
Breast Cancer
Transgender
Contraception
Lead sponsor: University Hospital, Bordeaux
Sponsor class: OTHER
First posted: 2024-04-10
Enrollment: 500
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Observational model: COHORT
Time perspective: PROSPECTIVE
Sampling method: NON_PROBABILITY_SAMPLE
Study population: Transgender people (male and female) will be approached via Trans associations (face-to-face and online) and the care networks in place at national level.

An online link for completing the questionnaire will be sent to trans associations and healthcare networks for distribution to the target population via a paper or digital flyer.

Brief summary: To date, the transgender population, still poorly characterized, tends to increase. The impact of gender-affirming hormone therapy (GAHT) in this population remains poorly understood, and few data are published on the gynecological repercussions of such therapy. A recent literature review by a French team suggests gynecological follow-up procedures for transgender people.

Detailed description: The hypothesis of this study is that transgender population in France does not have appropriate gynecological care, and the study would like to find out, directly from the people concerned, the current state of gynecological care for transgender people in France. To do this, ths study plan to send out a questionnaire to transgender people (via healthcare networks and also transgender associations) to ask them about their actual gynecological care and their knowledge of recommended gynecological care.

The aim is to set up a descriptive, declarative study based on a questionnaire created specifically for this work.

This project will use a questionnaire for transwomen people and another one for transmen people. Transgender people will be approached via Trans associations and healthcare networks. An online link to the questionnaire will be sent to trans associations and healthcare networks for distribution to the target population thanks to a flyer.

Eligibility criteria: Inclusion Criteria:

* French-speaking transgender person (transgender women or transgender men)
* age ≥18 years

Exclusion Criteria:

* age \<18 years

Primary outcomes:
measure: Percentage of people aware of gynaecological recommendations.
timeFrame: 24 months after inclusion day
Secondary outcomes:
measure: Percentage of people aware of cancer risks
timeFrame: 24 months after inclusion day
measure: Percentage of people aware of contraception in transgender male population
timeFrame: 24 months after inclusion day
measure: Percentage of people aware of fertility and the impact of hormone treatments
timeFrame: 24 months after inclusion day
measure: Percentage of people aware of gynaecological repercussions of masculinizing hormone treatment in transgender male population
timeFrame: 24 months after inclusion day
Other outcomes:
Locations:
city: Pessac
country: France
facility: Hopital Haut-Lévêque
Study officials:
References: